On a reported basis, annual revenue rose from KRW 19.8 billion in 2022 to KRW 29.9 billion in 2023 (up 51.3% year on year), KRW 36.1 billion in 2024 (up 20.7%) and KRW 38.9 billion in 2025 (up 7.8%).
Revenue has grown for three consecutive years, starting from 2022, and 2025 is the largest year in the 2022 to 2025 span. Operating profit, by contrast, fell 76.8% in 2025 to KRW 715 million, lowering the operating margin to 1.8%.
After a swing to operating profit of KRW 2.03 billion in 2023 and KRW 3.08 billion in 2024, 2025 gave back much of that gain. Management said staffing for supply-chain expansion and higher R&D spending raised costs.
The 2025 net loss attributable to controlling shareholders of KRW 16.3 billion, and a total net loss of KRW 16.8 billion, were linked in press reports to fair-value losses on composite financial instruments tied to the share price and to currency swings, after a KRW 9.74 billion profit in 2024.
Operating cash flow was negative in each year, moving from negative KRW 6.88 billion in 2022 to negative KRW 13.9 billion in 2025. The debt ratio fell from 389.4% in 2022 to 116.1% in 2025.
Total equity at the end of 2025 was KRW 38.6 billion, and equity attributable to controlling shareholders was KRW 45.5 billion, so the original filing's non-controlling interest line should be checked because total equity is smaller than the controlling portion.
Quarterly revenue bottomed at KRW 8.61 billion in Q4 2025 and then rose to KRW 9.5 billion, KRW 11.7 billion and KRW 12.2 billion across the first three quarters of 2026. Operating profit was KRW 106 million in Q1 2026, KRW 1.27 billion in Q2 and KRW 868 million in Q3, which was down 31.9% from the prior quarter.
The Q3 2026 net loss attributable to controlling shareholders of KRW 11.4 billion was reported to reflect higher overseas sales costs and a currency-translation loss from a lower exchange rate at quarter end.